Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis

Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	B. Maranini, G. Ciancio, R. Cultrera, M. Govoni
Formato:	article
Lenguaje:	EN IT
Publicado:	PAGEPress Publications 2021
Materias:	COVID-19 COVID-19 vaccine herpes zoster rheumatology. Medicine R Internal medicine RC31-1245
Acceso en línea:	https://doaj.org/article/df626525419b4e69ae7f6401aa8bb553
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:df626525419b4e69ae7f6401aa8bb553
record_format	dspace
spelling	oai:doaj.org-article:df626525419b4e69ae7f6401aa8bb5532021-11-23T08:18:52ZHerpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis10.4081/reumatismo.2021.14450048-74492240-2683https://doaj.org/article/df626525419b4e69ae7f6401aa8bb5532021-11-01T00:00:00Zhttps://www.reumatismo.org/index.php/reuma/article/view/1445https://doaj.org/toc/0048-7449https://doaj.org/toc/2240-2683 Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far. B. MaraniniG. CiancioR. CultreraM. GovoniPAGEPress PublicationsarticleCOVID-19COVID-19 vaccineherpes zosterrheumatology.MedicineRInternal medicineRC31-1245ENITReumatismo, Vol 73, Iss 3 (2021)
institution	DOAJ
collection	DOAJ
language	EN IT
topic	COVID-19 COVID-19 vaccine herpes zoster rheumatology. Medicine R Internal medicine RC31-1245
spellingShingle	COVID-19 COVID-19 vaccine herpes zoster rheumatology. Medicine R Internal medicine RC31-1245 B. Maranini G. Ciancio R. Cultrera M. Govoni Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
description	Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far.
format	article
author	B. Maranini G. Ciancio R. Cultrera M. Govoni
author_facet	B. Maranini G. Ciancio R. Cultrera M. Govoni
author_sort	B. Maranini
title	Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
title_short	Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
title_full	Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
title_fullStr	Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
title_full_unstemmed	Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
title_sort	herpes zoster infection following mrna covid-19 vaccine in a patient with ankylosing spondylitis
publisher	PAGEPress Publications
publishDate	2021
url	https://doaj.org/article/df626525419b4e69ae7f6401aa8bb553
work_keys_str_mv	AT bmaranini herpeszosterinfectionfollowingmrnacovid19vaccineinapatientwithankylosingspondylitis AT gciancio herpeszosterinfectionfollowingmrnacovid19vaccineinapatientwithankylosingspondylitis AT rcultrera herpeszosterinfectionfollowingmrnacovid19vaccineinapatientwithankylosingspondylitis AT mgovoni herpeszosterinfectionfollowingmrnacovid19vaccineinapatientwithankylosingspondylitis
_version_	1718416855549345792

Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis

Ejemplares similares